z-logo
Premium
Nitric oxide‐dependent relaxation induced by M 1 muscarinic receptor activation in the rat small intestine
Author(s) -
Olgart C,
Iversen H H
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702529
Subject(s) - muscarinic acetylcholine receptor , muscarinic acetylcholine receptor m1 , chemistry , endocrinology , hexamethonium , muscarinic acetylcholine receptor m3 , medicine , muscarinic acetylcholine receptor m2 , guanethidine , agonist , nitric oxide synthase , nitric oxide , receptor , acetylcholine , pharmacology , biology , biochemistry , stimulation
The aim of the present study was to investigate whether muscarinic M 1 receptor activation induces intestinal relaxation via nerve‐dependent nitric oxide formation. Mechanical activity in longitudinal segments of rat jejunum was recorded isotonically in organ baths. The muscarinic M 1 receptor agonist 4‐[[[(3‐Chlorophenyl)amino]carbonyl]oxy]‐N,N,N,‐trimethyl‐2‐butyn‐1‐amonium chloride (McN‐A‐343, 10 −7 –10 −4   M ) induced a concentration‐dependent relaxation of rat jejunum. Relaxations induced by McN‐A‐343 (10 −5   M ) were inhibited by the M 1 receptor antagonist telenzepine (10 −8   M ), and enhanced by the M 3 receptor antagonist para‐fluoro‐hexahydrosiladifenidol (p‐F‐HHSiD; 3×10 −7   M ). The inhibitory responses induced by McN‐A‐343 were abolished by the nitric oxide synthase inhibitors N ω ‐nitro‐ L ‐arginine ( L ‐NOARG; 10 −4   M ) and N ω ‐monomethyl‐ L ‐arginine ( L ‐NMMA; 3×10 −5   M ), the guanylyl cyclase inhibitor 1H‐[1,2,4]oxadiazolo[4,3,‐a]quinoxalin‐1‐one (ODQ; 10 −5   M ), and by tetrodotoxin (TTX; 3×10 −7   M ). Guanethidine or hexamethonium did not affect inhibitory responses induced by McN‐A‐343. In conclusion, McN‐A‐343 induces nerve‐dependent, nitrergic relaxations in rat jejunum, via activation of muscarinic M 1 receptors. Hence, selective muscarinic M 1 receptor agonists or antagonists might offer possibilities for pharmacological manipulation of the NO system.British Journal of Pharmacology (1999) 127 , 309–313; doi: 10.1038/sj.bjp.0702529

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom